Volume 97, Issue 8, Pages (August 2003)

Slides:



Advertisements
Similar presentations
Dr. Taj. What is Spirometry ? It is a measurement of the breathing capacity of the lungs. It is the most basic and frequently performed test of pulmonary.
Advertisements

CC Chemokine Receptor 5 and CXC Chemokine Receptor 6 Expression by Lung CD8+ Cells Correlates with Chronic Obstructive Pulmonary Disease Severity Christine.
The evolving role of MDCT in the assessment of patients with chronic obstructive pulmonary disease S. Karia, R. Mahadeva, A. Balan, J. Babar Clinical Radiology.
Adherence to pulmonary rehabilitation: A qualitative study
S.R Salpeter, T.M Ormiston, E.E Salpeter, P.J Poole, C.J Cates 
Volume 101, Issue 12, Pages (December 2007)
Volume 390, Issue 10098, Pages (September 2017)
Volume 108, Issue 1, Pages (January 2014)
Ultrasound of Internal Jugular Veins and Correlation to Pulmonary Edema in Emergency Department Patients a Double Blinded Study  B.S. Tzadok, M.A. Egbaria,
Obesity and pulmonary function testing
A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis 
Copyright © 2015 by the American Osteopathic Association.
Céline Pynnaert, Michel Lamotte, Robert Naeije  Respiratory Medicine 
Asthma Phenotypes Defined From Parameters Obtained During Recovery From a Hospital-Treated Exacerbation  Rihuang Qiu, MD, Jiaxing Xie, MD, PhD, Kian Fan.
Simple versus complex COPD: implications for health-care management
Monica M. Vasquez, MPH, Leslie A. McClure, PhD, Duane L
Chronic obstructive pulmonary disease (COPD)
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Meghan E. Sise, Andrew M. Courtwright, Richard N. Channick 
Comorbidity in chronic obstructive pulmonary disease
M. Inghammar, G. Engström, G. Kahlmeter, B. Ljungberg, C. -G
Anemia management in chronic kidney disease
Shireen Mirza, MBBS, Roberto Benzo, MD  Mayo Clinic Proceedings 
Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure  Jacques D. Donzé, MD, MSc, Patrick.
Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disease: A Practical Guide for Clinicians  Kylie Hill, PhD, Nola M. Cecins,
Relationship between the change in a) ventilatory and b) cerebrovascular responses in older healthy subjects (Older) and chronic obstructive pulmonary.
Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu.
From the Feds: Research, programs, and products
Personalized Disease Models on a Chip
Genetics of lung cancer susceptibility and COPD
R. Graham Barr, MD, DrPH, Bartolome R. Celli, MD, Fernando J
Elucidating COPD pathogenesis by large-scale genetic analyses
Influence of do-not-resuscitate (DNR) order specification on overall survival in chronic obstructive pulmonary disease (COPD) patients (log rank test p
Immunostaining for lipid peroxidation product 4-hydroxy-2-nonenal (4-HNE) adduct in the lungs of smokers with and without chronic obstructive pulmonary.
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
Training for the infectious diseases speciality in Norway
Venn diagram showing the overlap between the various chronic obstructive pulmonary disease (COPD) diagnoses: self-reported physician-diagnosed, fixed ratio.
Point: Should We Abandon FEV1/FVC <0
Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care by Francis Nissen, Daniel R Morales, Hana Mullerova, Liam Smeeth, Ian.
A white elephant or the elephant in the room
Meta-analysis of the Effect of a Pulmonary Rehabilitation Program on Respiratory Muscle Strength in Patients with Chronic Obstructive Pulmonary Disease 
Comparison of the age-associated prevalence (y axis) in the Catalan Healthcare Surveillance System (CHSS) and Medicare datasets of selected disease groups.
Volume 97, Issue 1, Pages (January 1990)
Volume 74, Issue 3, Pages (August 2008)
Personalized Disease Models on a Chip
The impact of smoking in primary spontaneous pneumothorax
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Adjustment for do-not-resuscitate orders reverses the apparent in-hospital mortality advantage for minorities  Naomi Bardach, MD, Shoujun Zhao, MD, PhD,
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
Kaplan–Meier survival curves for outcomes among chronic obstructive pulmonary disease (COPD) patients without obstructive sleep apnoea (OSA) (COPD group),
Metabolic Syndrome in South Korean Patients with Chronic Obstructive Pulmonary Disease: A Focus on Gender Differences  Jinhee Kim, Jae Yong Yoo, Hee Sun.
A) Levels of nitrosothiols in breath condensate in normal healthy smokers and patients with chronic obstructive pulmonary disease (COPD). b) Increased.
Morbidity and mortality benefits with statin use in observational studies on a logarithmic scale. Morbidity and mortality benefits with statin use in observational.
Scatter plot of body mass index (BMI) versus forced expiratory volume in the first second (FEV1), and linear correlation lines for normal spirometry and.
A) 8-isoprostane levels in exhaled breath condensate in smokers with chronic obstructive pulmonary disease (COPD). *: p
Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disease: A Practical Guide for Clinicians  Kylie Hill, PhD, Nola M. Cecins,
Distribution of patients in the first- or second-year follow-up according to the number of acute exacerbations of chronic obstructive pulmonary disease.
Pathophysiological interactions between chronic obstructive pulmonary disease (COPD), sleep and obstructive sleep apnoea syndrome (OSAS). Pathophysiological.
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease  Fabio L.M. Ricciardolo, MD, Gaetano Caramori, MD, PhD, Kazuhiro.
Schematic diagram of the shared subgroups between asthma and chronic obstructive pulmonary disease (COPD). Schematic diagram of the shared subgroups between.
Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.
Decision-Making in Patients With Cancer and Kidney Disease
Exercise in Individuals With CKD: A Focus Group Study Exploring Patient Attitudes, Motivations, and Barriers to Exercise  Jessica Kendrick, Michael Ritchie,
Distribution of NEWS in the community by service
Scatterplots showing baseline correlation between forced expiratory volume in 1 s (FEV1) % pred and a) COPD Assessment Test (CAT), b) Clinical COPD Questionnaire.
Chronic obstructive pulmonary disease (COPD) prevalence (postbronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity)
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Interventional bronchoscopic and surgical treatments.
Interleukin (IL)-1β and IL-18 in stable chronic obstructive pulmonary disease (COPD) patients. a) IL-1β and IL-18 relative transcript levels in lung tissues.
The natural history of chronic obstructive pulmonary disease (COPD) is a mixture of the natural history of the various phenotypes making up the umbrella.
Presentation transcript:

Volume 97, Issue 8, Pages 983-989 (August 2003) Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma  K Spiropoulos, G Trakada, E Nikolaou, E Prodromakis, G Efremidis, A Pouli, A Koniavitou  Respiratory Medicine  Volume 97, Issue 8, Pages 983-989 (August 2003) DOI: 10.1016/S0954-6111(03)00129-X

Figure 1 FEV1/FVC ratio in asthmatic and COPD “non-desaturators” and “desaturators” patients. Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)

Figure 2 SatO2 in asthmatic and COPD “non-desaturators” and “desaturators” patients during daytime. Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)

Figure 3 ET-1 in asthmatic and COPD “non-desaturators” and “desaturators” patients and normal controls during daytime. Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)

Figure 4 ET-1 in “desaturators” COPD patients during daytime and during sleep. Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)

Figure 5 Correlation of SatO2 and ET-1 levels in “desaturators” COPD patients during sleep (P<0.001, r=−0.939). Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)

Figure 6 Correlation of SatO2 and ET-1 levels in “desaturators” COPD patients during daytime (P=0.005, r=−0.632). Respiratory Medicine 2003 97, 983-989DOI: (10.1016/S0954-6111(03)00129-X)